Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease.
about
Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activationThe intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2bcl-2 gene enables rescue from in vitro myelosuppression (bone marrow cell death) induced by chemotherapyThe p53-binding protein 53BP2 also interacts with Bc12 and impedes cell cycle progression at G2/MThe Bcl-2 apoptotic switch in cancer development and therapyPhysical map of human 6p21.2-6p21.3: region flanking the centromeric end of the major histocompatibility complexProtein phosphatase subunit G5PR is needed for inhibition of B cell receptor-induced apoptosisDeath by a B cell superantigen: In vivo VH-targeted apoptotic supraclonal B cell deletion by a Staphylococcal ToxinIrod/Ian5: an inhibitor of gamma-radiation- and okadaic acid-induced apoptosisBasal immunoglobulin signaling actively maintains developmental stage in immature B cells.The cancer stem cell: evidence for its origin as an injured autoreactive T cellLinking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosusDisruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancerTissue expression and subcellular localization of the pro-survival molecule Bcl-wApoptosis timelineDevelopmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytesEssential role of BAX,BAK in B cell homeostasis and prevention of autoimmune diseaseA gammaherpesvirus Bcl-2 ortholog blocks B cell receptor-mediated apoptosis and promotes the survival of developing B cells in vivoBCMA is essential for the survival of long-lived bone marrow plasma cellsThe folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dubé syndrome is required for murine B-cell developmentTransgenic models of lymphoid neoplasia and development of a pan-hematopoietic vectorHumanized Immunoglobulin Mice: Models for HIV Vaccine Testing and Studying the Broadly Neutralizing Antibody Problem.Inositol 1,3,4,5-tetrakisphosphate controls proapoptotic Bim gene expression and survival in B cells.Inhibition of NF-kappaB activation in vivo impairs establishment of gammaherpesvirus latency.p27 deficiency cooperates with Bcl-2 but not Bax to promote T-cell lymphoma.ABT-199, a new Bcl-2-specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia.Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein.Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivoFAS is highly expressed in the germinal center but is not required for regulation of the B-cell response to antigenThe role of apoptosis proteins and complement components in the etiopathogenesis of systemic lupus erythematosus.Apotosis of mature B cells.Apoptosis in human autoimmune diseases.Peripheral B cell tolerance and function in transgenic mice expressing an IgD superantigen.Flt3 signaling regulates the proliferation, survival, and maintenance of multipotent hematopoietic progenitors that generate B cell precursors.Inhibition of apoptosis and clonogenic survival of cells expressing crmA variants: optimal caspase substrates are not necessarily optimal inhibitorsProtamine and protamine-insulins exacerbate the vascular response to injury.GATA-1 but not SCL induces megakaryocytic differentiation in an early myeloid lineCurrent evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy.Deletion of immunoglobulin beta in developing B cells leads to cell death.The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers
P2860
Q24307782-FAF663E5-55CA-4B8A-B5E6-DDEA87F7EC42Q24317954-407F781F-3FD9-4EFC-AE4C-45F7D231D53AQ24319116-10DBD6EE-4F4B-4D2B-ACDA-01B4084A75BCQ24323137-C1795B31-28DA-4551-9D29-CE279D5C0248Q24620437-2EE8BFE6-202E-41ED-A6D4-1749CCC4A30FQ24627151-B4BB8E1C-7454-4797-B78C-B35816A9EDF4Q24646492-F4413F3B-6948-4887-843B-6DBABD0834CBQ24673297-F7F22E74-7E21-4953-858C-941A31CBCDB2Q24682548-B4F2D47D-7AF8-40D9-82D8-F6F1A9EC7528Q24795003-216C8458-AF06-473B-9B27-90F806956262Q25256839-9C4A57A4-7C60-4B51-A9E8-6706D4FA2D6FQ26822662-C264355F-FBD9-4DF3-91C8-AFD842D70F19Q27020978-18F35E18-DB3D-4216-BD26-7BD3E443A9C9Q28203506-97E92886-E0B8-4513-A2DB-D4E712838F0CQ28215321-072CFDED-3DE4-42FB-B6B6-B3EDDF92E73CQ28510299-19D7CDCF-90B6-4A76-AA9E-664E341A4F61Q28513752-F32ABDDB-B4A1-4A99-B178-E25E2FBBA357Q28539635-D2AF2244-23C3-4A2F-8973-B0C11592CC8BQ28587037-25600C91-18FE-4F5E-8501-2FDCDAAF9B2CQ28587887-EF9BD878-9785-48ED-A73F-5967D72DC29CQ28592731-53F7CA54-7B86-4F32-ACAD-8795AB5F139AQ30234773-358C9510-AC7E-4245-9865-5488455DF8E8Q30479990-9F86E5D5-E65E-485F-BB74-7D4D53D0ECA6Q33270518-4C262306-B064-4097-9DAC-4F3071313590Q33326639-43FAD06C-90C5-48F7-BDC4-F7DF68A6B603Q33405436-8512BB4A-18DB-45EF-8CE8-A47FB2394E52Q33493389-4C1C56F2-EE5B-4F87-BEA2-945CDEBA0B81Q33615157-90AA32EA-0191-40B6-BBBF-713AA188A3A5Q33711133-E72E7B11-4D0A-479D-91E9-625F59737D0AQ33754111-A9D7C02B-843D-400A-A5E5-F704D9F7F14AQ33811739-A3D76B7E-F77B-49A2-92A2-87981DC7DA94Q33836352-8776DEFF-D20B-4818-816C-0B03D15CC66BQ33869858-FFACD1D7-AE42-48FF-B8D7-B3B8D0263A9DQ33873934-A9954EBA-42B1-4638-A1E7-7CD3A2913937Q33890314-4D554C0B-DD61-4FE6-ABA5-5DFCFF0256D8Q33900462-6814917C-AE4C-4312-97E6-BD093E1F5940Q33938789-6F20504A-E6A5-4EF6-8291-24082A5FAA7CQ33973488-6C5395DF-4280-42D9-B0DF-E3AA404B967FQ34038194-78822E81-8425-4DB5-B42D-9183E4BE237CQ34044132-5D88C2E7-A46F-4F94-AE77-07AB30F7A0C2
P2860
Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enforced BCL2 expression in B- ...... nd elicits autoimmune disease.
@en
Enforced BCL2 expression in B- ...... nd elicits autoimmune disease.
@nl
type
label
Enforced BCL2 expression in B- ...... nd elicits autoimmune disease.
@en
Enforced BCL2 expression in B- ...... nd elicits autoimmune disease.
@nl
prefLabel
Enforced BCL2 expression in B- ...... nd elicits autoimmune disease.
@en
Enforced BCL2 expression in B- ...... nd elicits autoimmune disease.
@nl
P2093
P2860
P356
P1476
Enforced BCL2 expression in B- ...... nd elicits autoimmune disease.
@en
P2093
P2860
P304
P356
10.1073/PNAS.88.19.8661
P407
P577
1991-10-01T00:00:00Z